NCT00001748
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +25 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States
Clinical trial condition
Myeloproliferative Disorders
Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.
500 public trials
86 recruiting studies
Myeloproliferative Disorders trial results
Active, Not Recruiting
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant
NCT02506933
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +43 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
NCT06468033
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Levine Cancer Institute Charlotte, North Carolina, United States
- University of Yamanashi Hospital Chūō, Yamanashi, Japan
Active, Not Recruiting
Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance
NCT04285086
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
- Locations
-
- Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
- Washington University School of Medicine - Division of Oncology St Louis, Missouri, United States
- MD Anderson Cancer Center Houston, Texas, United States
- University of Utah Salt Lake City, Utah, United States
Active, Not Recruiting
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +17 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- UCLA Medical Center Los Angeles, California, United States
- University of California, Davis - Health Systems Sacramento, California, United States
- H Lee Moffitt Cancer Center Tampa, Florida, United States
Active, Not Recruiting
Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm
NCT05600894
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +20 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UCI Health Laguna Hills Laguna Hills, California, United States
Active, Not Recruiting
Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT03862157
- Conditions
- Acute Myeloid Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blood Coagulation Disorders, +43 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04717414
- Conditions
- Anemia, Bone Marrow Diseases, Hematologic Diseases, +5 more
- Locations
-
- Local Institution - 110 Los Angeles, California, United States
- Local Institution - 135 Orlando, Florida, United States
- Local Institution - 133 Plantation, Florida, United States
- Local Institution - 112 Chicago, Illinois, United States
Active, Not Recruiting
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
NCT04576156
- Conditions
- Blood Platelet Disorders, Bone Marrow Diseases, Hematologic Diseases, +6 more
- Locations
-
- University of California-San Diego/Moores UCSD Cancer Center La Jolla, California, United States
- UCLA David Geffen School of Medicine Los Angeles, California, United States
- Smilow Cancer Center at YNHH New Haven, Connecticut, United States
- BRCR Medical Center Inc Plantation, Florida, United States
NCT04802161
- Conditions
- Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, Acute Myeloid Leukemia With Multilineage Dysplasia, +19 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Kansas Cancer Center Kansas City, Kansas, United States
- University of Kansas Hospital-Westwood Cancer Center Westwood, Kansas, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States